miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2
The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
Colorectal carcinoma is a frequent cause of cancer-related death in men and women. miRNAs (microRNAs) are endogenous small non-coding RNAs that regulate gene expression negatively at the post-transcriptional level. In the present study we investigated the possible role of microRNAs in the development of MDR (multidrug resistance) in colorectal carcinoma cells. We analysed miRNA expression levels between MDR colorectal carcinoma cell line HCT116/L-OHP cells and their parent cell line HCT116 using a miRNA microarray. miR-297 showed lower expression in HCT116/L-OHP cells compared with its parental cells. MRP-2 (MDR-associated protein 2) is an important MDR protein in platinum-drug-resistance cells and is a predicted target of miR-297. Additionally miR-297 was down-regulated in a panel of human colorectal carcinoma tissues and negatively correlated with expression levels of MRP-2. Furthermore, we found that ectopic expression of miR-297 in MDR colorectal carcinoma cells reduced MRP-2 protein level and sensitized these cells to anti-cancer drugs in vitro and in vivo. Taken together, our findings suggest that miR-297 could play a role in the development of MDR in colorectal carcinoma cells, at least in part by modulation of MRP-2.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, several studies have demonstrated that using miRNA mimics to increase the levels of specific miRNAs, such as miR-133b, miR-142-3p, miR-297, and miR-522, can increase the chemosensitivity of drug-resistant CRC cells [104,105,106,107].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [104]
Citations
Cites
1 retracted
Liang, Z., Wu, H., Reddy, S., Zhu, A., Wang, S., Blevins, D. P., Yoon, Y., Zhang, Y., & Shim, H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.09.007 · Cited by 126
RetractedJemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Real-time quantification of microRNAs by stem-loop RT-PCR
Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,952
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
microRNAs as oncogenes and tumor suppressors
Zhang, B., Pan, X., Cobb, G. P., & Anderson, T. A. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.028 · Cited by 2,749
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
Xie, X., Lu, J., Kulbokas, E. J., Golub, T. R., Mootha, V., Lindblad-Toh, K., Lander, E. S., & Kellis, M. (2005) · Nature · doi:10.1038/nature03441 · Cited by 1,872
Endogenous human microRNAs that suppress breast cancer metastasis
Tavazoie, S. F., Alarcón, C., Oskarsson, T., Padua, D., Wang, Q., Bos, P. D., Gerald, W. L., & Massagué, J. (2008) · Nature · doi:10.1038/nature06487 · Cited by 1,857
Si, M.-L., Zhu, S., Wu, H., Lu, Z., Wu, F., & Mo, Y.-Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210083 · Cited by 1,600
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α
Moss, M. L., Jin, S.-L. C., Milla, M. E., Burkhart, W., Carter, H. L., Chen, W.-J., Clay, W. C., Didsbury, J. R., Hassler, D., Hoffman, C. R., et al. (1997) · Nature · doi:10.1038/385733a0 · Cited by 1,378
Phylogenetic Shadowing and Computational Identification of Human microRNA Genes
Berezikov, E., Guryev, V., van de Belt, J., Wienholds, E., Plasterk, R. H. A., & Cuppen, E. (2005) · Cell · doi:10.1016/j.cell.2004.12.031 · Cited by 1,270
The discovery of receptor tyrosine kinases: targets for cancer therapy
Gschwind, A., Fischer, O. M., & Ullrich, A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1360 · Cited by 1,227
Lim, L. P., Glasner, M. E., Yekta, S., Burge, C. B., & Bartel, D. P. (2003) · Science · doi:10.1126/science.1080372 · Cited by 1,217
ADAMs: key components in EGFR signalling and development
Blobel, C. P. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1548 · Cited by 1,090
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S., & Mo, Y.-Y. (2008) · Cell Research · doi:10.1038/cr.2008.24 · Cited by 1,051
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
Huang, Q., Gumireddy, K., Schrier, M., le Sage, C., Nagel, R., Nair, S., Egan, D. A., Li, A., Huang, G., Klein-Szanto, A. J., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1681 · Cited by 975
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Shuomin, Zhu, Hailong, H., Wu, Fangting, Daotai, Nie, Shijie, Sheng, Yin-Yuan, et al. (2008) · Cell Research · Cited by 831
MicroRNAs as Oncogenes and Tumor Suppressors
Chen, C.-Z. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058190 · Cited by 758
A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes
Kent, O. A., & Mendell, J. T. (2006) · Oncogene · doi:10.1038/sj.onc.1209913 · Cited by 720
OncomiRs: the discovery and progress of microRNAs in cancers
Cho, W. C. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-60 · Cited by 719
miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
Xia, L., Zhang, D., Du, R., Pan, Y., Zhao, L., Sun, S., Hong, L., Liu, J., & Fan, D. (2008) · International Journal of Cancer · doi:10.1002/ijc.23501 · Cited by 711
Self-citationKovalchuk, O., Filkowski, J., Meservy, J., Ilnytskyy, Y., Tryndyak, V. P., Chekhun, V. F., & Pogribny, I. P. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0021 · Cited by 635
MicroRNA Biogenesis and Cancer
Gregory, R. I., & Shiekhattar, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0298 · Cited by 613
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors
Dickins, R. A., Hemann, M. T., Zilfou, J. T., Simpson, D. R., Ibarra, I., Hannon, G. J., & Lowe, S. W. (2005) · Nature Genetics · doi:10.1038/ng1651 · Cited by 524
Haimeur, A., Conseil, G., Deeley, R., & Cole, S. (2004) · Current Drug Metabolism · doi:10.2174/1389200043489199 · Cited by 485
Zhu, H., Wu, H., Liu, X., Evans, B. R., Medina, D. J., Liu, C.-G., & Yang, J.-M. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.007 · Cited by 456
Shedding light on ADAM metalloproteinases
Huovila, A.-P. J., Turner, A. J., Pelto-Huikko, M., Kärkkäinen, I., & Ortiz, R. M. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.05.006 · Cited by 453
A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA)
Castoldi, M., Schmidt, S., Benes, V., Noerholm, M., Kulozik, A. E., Hentze, M. W., & Muckenthaler, M. U. (2006) · RNA · doi:10.1261/rna.2332406 · Cited by 429
Liang, Z., Wu, H., Xia, J., Li, Y., Zhang, Y., Huang, K., Wagar, N., Yoon, Y., Cho, H. T., Scala, S., et al. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.10.017 · Cited by 330
Pan, Y.-Z., Morris, M. E., & Yu, A.-M. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.054163 · Cited by 309
Strategies to determine the biological function of microRNAs
Krützfeldt, J., Poy, M. N., & Stoffel, M. (2006) · Nature Genetics · doi:10.1038/ng1799 · Cited by 259
Bailey-Dell, K. J., Hassel, B., Doyle, L. A., & Ross, D. D. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(01)00270-6 · Cited by 225
Blanchot‐Jossic, F., Jarry, A., Masson, D., Bach‐Ngohou, K., Paineau, J., Denis, M. G., Laboisse, C. L., & Mosnier, J. (2005) · The Journal of Pathology · doi:10.1002/path.1814 · Cited by 140
Zhao, J., Chen, H., Peschon, J. J., Shi, W., Zhang, Y., Frank, S. J., & Warburton, D. (2001) · Developmental Biology · doi:10.1006/dbio.2001.0176 · Cited by 122
Mechanisms of tumor resistance to EGFR-targeted therapies
Hopper-Borge, E. A., Nasto, R. E., Ratushny, V., Weiner, L. M., Golemis, E. A., & Astsaturov, I. A. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14712590902735795 · Cited by 119
TACE is required for fetal murine cardiac development and modeling
Shi, W., Chen, H., Sun, J., Buckley, S., Zhao, J., Anderson, K. D., Williams, R. G., & Warburton, D. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00315-4 · Cited by 115
Kyula, J. N., Van Schaeybroeck, S., Doherty, J., Fenning, C. S., Longley, D. B., & Johnston, P. G. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0014 · Cited by 99
Ohtani, H., Tamamori, Y., Arimoto, Y., Nishiguchi, Y., Maeda, K., & Hirakawa, K. (2011) · Journal of Cancer · doi:10.7150/jca.2.425 · Cited by 81
The ADAMs family of proteins: from basic studies to potential clinical applications
Lynn, D., Lloyd, A., O’Shea, C., & Duffy, M. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613568 · Cited by 75
Tsuda, N., Kawano, K., Efferson, C. L., & Ioannides, C. G. (2005) · International Journal of Oncology · doi:10.3892/ijo.27.5.1299 · Cited by 45
Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy
Kuwai, T., Nakamura, T., Sasaki, T., Kitadai, Y., Kim, J.-S., Langley, R. R., Fan, D., Wang, X., Do, K.-A., Kim, S.-J., et al. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9153-7 · Cited by 44
Hoffmann, K., Xiao, Z. Q., Franz, C., Mohr, E., Serba, S., Büchler, M. W., & Schemmer, P. (2011) · Cancer Cell International · doi:10.1186/1475-2867-11-40 · Cited by 25
Effects of MDR1/P-glycoprotein expression on prognosis in advanced colorectal cancer after surgery
Tokunaga, Y., Hosogi, H., Hoppou, T., Nakagami, M., Tokuka, A., & Ohsumi, K. (2001) · Oncology Reports · doi:10.3892/or.8.4.815 · Cited by 17
Andersen, V. C., Agerstjerne, L., Jensen, D., Østergaard, M., Sæbø, M., Hamfjord, J., Kure, E. H., & Vogel, U. B. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-18 · Cited by 15
Multidrug-resistance proteins are weak tumor associated antigens for colorectal carcinoma
Mullins, C. S., Eisold, S., Klar, E., & Linnebacher, M. (2011) · BMC Immunology · doi:10.1186/1471-2172-12-38 · Cited by 7
Research works printed but not linked: 2
- Tokunaga, 2001, Effects of after surgery, Oncol. Rep., 8, 815
- Pan, 2009, MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells, Mol. Pharmacol., 75, 1374, 10.1124/mol.108.054163 · DOI · Paper page
Cited by
The sinister face of heme oxygenase-1 in brain aging and disease
Schipper, H. M., Song, W., Tavitian, A., & Cressatti, M. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.06.008 · Cited by 200
Multidrug Resistance Proteins (MRPs) and Cancer Therapy
Zhang, Y.-K., Wang, Y.-J., Gupta, P., & Chen, Z.-S. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9757-1 · Cited by 196
MicroRNAs and cancer stem cells: the sword and the shield
Sun, X., Jiao, X., Pestell, T. G., Fan, C., Qin, S., Mirabelli, E., Ren, H., & Pestell, R. G. (2014) · Oncogene · doi:10.1038/onc.2013.492 · Cited by 161
Dai, X., & Tan, C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.010 · Cited by 155
MicroRNAs: Clinical Relevance in Colorectal Cancer
Thomas, J., Ohtsuka, M., Pichler, M., & Ling, H. Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226080 · Cited by 131
Metadata
- Authors
- Xu, K., Liang, X., Shen, K., Cui, D., Zheng, Y., Xu, J., Fan, Z., Qiu, Y., Li, Q., Ni, L., & Liu, J.
- Affiliations
- East China University of Science and Technology (CN)
- Shanghai University of Traditional Chinese Medicine (CN)
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Xu, Ke
- Liang, Xin
- Shen, Ke
- Cui, Daling
- Zheng, Yuanhong
- Liu, Jianwen
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2012-08-14
- Volume
- 446
- Issue
- 2
- Pages
- 291-300
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W2001233915
- Cited by
- 93
- References
- 51
- Citations by year
- 2025: 4 · 2024: 4 · 2023: 2 · 2022: 6 · 2021: 9 · 2020: 7 · 2019: 7 · 2018: 6 · 2017: 7 · 2016: 15 · 2015: 7 · 2014: 10 · 2013: 7 · 2012: 2
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- microRNA, multidrug resistance, colorectal cancer, MRP2, TAP1, platinum resistance, chemosensitization, miRNA expression profiling, efflux pumps
- MeSH terms
- Multidrug Resistance-Associated Protein 2, Adenocarcinoma, Aged, Antineoplastic Agents, Female, Humans, Male, Middle Aged, Neoplasm Proteins, RNA, Messenger, RNA, Neoplasm, Colorectal Neoplasms, Genetic Therapy, Down-Regulation, Drug Resistance, Multiple, Drug Resistance, Neoplasm, Gene Silencing, ATP-Binding Cassette, Sub-Family C Proteins, Multidrug Resistance-Associated Proteins, RNA, Small Interfering, MicroRNAs, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.